Maria Τektonidou: TMN Manifestation Scores and Mortality in Antiphospholipid Syndrome
Maria Τektonidou, Professor of Rheumatology at National and Kapodistrian University of Athens, shared a post on LinkedIn, about a recent article she and her colleagues co-authored, adding:
“Further Validation of the Eular Antiphospholipid syndrome disease activity score (Eapsdas). Criterion Validity using mortality as the criterion.
The maximum scores of thrombotic/microvascular/non-thrombotic (TMN) manifestations were significantly higher among patients who died due to Antiphospholipid Syndrome than among those who survived and those who died from other causes”
Title: Criterion validity of the EULAR Antiphospholipid Syndrome Disease Activity Score (EAPSDAS)
Authors: Maria G. Tektonidou, Ricard Cervera , Guillermo J. Pons-Estel , Savino Sciascia, Angela Tincani , Michael M. Ward
Read the Full Article on Annals of the Rheumatic Diseases
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?